SEP 3, 2026 · JOURNAL ARTICLE
Integrated Transcriptomics and Lipidomics Identify CES1-Mediated Maladaptive Lipolysis as a Key Target of Hyperlipidemic Acute Pancreatitis
Metabolites
Mechanistic discovery study combining transcriptomics, lipidomics, and a validated mouse model showing proof-of-mechanism for CES1 inhibition in hyperlipidemic acute pancreatitis, but limited to preclinical validation without human efficacy data.
Reported
Diagnostic accuracy of three-gene…excellent
CES1 correlation with neutrophil…strong